User:jakubsntu065657

Datopotamab Deruxtecan, often abbreviated as DATO, represents the important advancement regarding targeted cancer treatment. This novel antibody-drug conjugate joins a monoclonal immunoglobulin

https://www.targetmol.com/compound/datopotamab